We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





CT Values Should Not Be Used to Assess Performance of SARS-CoV-2 PCR Tests or Triage COVID-19 Patients, Finds Study

By LabMedica International staff writers
Posted on 13 Oct 2021
Print article
Illustration
Illustration

A novel study has shown that coronavirus test cycle threshold (Ct) values should not be used to assess the performance of coronavirus tests or to triage COVID-19 patients.

These findings of the study by an international group of scientists, led by the National Measurement Laboratory for Chemical and Bio-Measurement team at LGC (Middlesex, UK), could improve the development of coronavirus tests, which are crucial for managing the pandemic, as well as care for COVID-19 patients.

When a patient gets a standard coronavirus test - known as a PCR test - Ct values are generated as part of the testing process. These values are also commonly known as Cq or Cp values. In WHO’s recommendations for coronavirus test developers and funders, the organization proposes a Ct of 25 as the minimum level of virus that should be detected by point-of-care coronavirus tests (i.e., tests that can be performed near the patient). Some research has also suggested that Ct values could potentially identify patients who have high viral loads and are at increased risk for serious disease. However, in July of this year, the American Association for Clinical Chemistry (AACC) had issued a public statement advising against the use of these values to guide COVID-19 public health efforts or treatment due to a lack of conclusive data supporting this.

In an effort to fill this data gap, the international team of researchers set out to determine how the WHO’s suggested Ct cut-off of 25 impacts coronavirus test performance. To do this, the researchers analyzed the results of more than 6,000 patients who underwent coronavirus PCR testing at three clinical laboratories in the UK, Belgium, and the Republic of Korea. For the purposes of this study, all PCR tests used were considered to have 100% clinical sensitivity (i.e., the ability to correctly identify patients with COVID-19 100% of the time). However, when the team interpreted the tests’ results using the WHO’s cut-off, the tests’ clinical sensitivity dropped, varying from approximately 16% to 90% depending on the patient cohort.

Further analysis of data from 732 additional laboratories found that an individual Ct value can correspond to widely differing viral loads depending on the lab. For example, in theory, the Ct value range of 25-30 corresponds to 106 copies of SARS-CoV-2/mL. In reality, however, the researchers found that that Ct range can correspond to as many as 108 copies/mL to as few as 103 copies/mL. When taken altogether, these results showed that Ct values should not be used to guide test development or to determine a patient’s prognosis.

“While [Ct] values may be useful in COVID-19 for epidemiological assessments of populations, they should be avoided as a quantitative measure for individual patient stratification or … analytical performance targets,” said Jim Huggett, PhD, of the U.K. National Measurement Laboratory at LGC, who led the research team. “If quantification is to be performed, copy based units calibrated to appropriate standards should be explored as applied in other areas of clinical virology. When dealing with a new pathogen, this fact is hampered by an initial absence of appropriate standards to calibrate the copy based units; consequently; their rapid production should be an important part of diagnostic response plan to a new epidemic.”

Related Links:
LGC 

Gold Supplier
SARS-CoV-2/Flu A/B & RSV Test
RespiBio Panel 3 (RBRP3)
New
GADAb ELISA Assay
KRONUS Glutamic Acid Decarboxylase Autoantibody (GADAb) ELISA Assay Kit
New
Anti-SARS-CoV-2 Controls Kit
ACCURUN Anti-SARS-CoV-2 Controls Kit
New
Gold Supplier
BMP Whole Blood Analyzer
GEM Premier ChemSTAT

Print article

Channels

Molecular Diagnostics

view channel
Image: A cancer cell during cell division (Photo courtesy of [U.S.] National Institutes of Health)

New Method Promises Rapid Isolation of Biomarker-Rich Extracellular Vesicles

A new method for isolating and analyzing cancer biomarkers from extracellular vesicles present in biological fluids is based on a novel magnetic particle based liquid biopsy chip. Extracellular vesicles... Read more

Microbiology

view channel
Image: Colored Transmission electron micrograph of Clostridium difficile bacterium forming an endospore (lower right, red oval). Clostridium difficile produce a toxin that irritates the colon and causes diarrhea (Photo courtesy of Kari Lounatmaa, PhD)

Quantity of Toxin in Stool Correlates with C. difficile Severity

Clostridioides difficile (syn. Clostridium difficile), also known as C. difficile, or C. diff are Gram-positive species of spore-forming bacteria. Clostridioides spp. are anaerobic, motile bacteria, ubiquitous... Read more

Technology

view channel
Image: Non-Invasive Nasal Swab Test Leverages Advanced Genomic Technology to Detect Lung Cancer Risk (Photo courtesy of Veracyte, Inc.)

Non-Invasive Nasal Swab Test Leverages Advanced Genomic Technology to Detect Lung Cancer Risk

A novel, non-invasive nasal swab test could support more timely and accurate lung nodule diagnosis. Veracyte, Inc. (South San Francisco, CA, USA) has announced that new expanded clinical validation data... Read more

Industry

view channel
Image: VSE Cat. No. 84800 with optional mobile table and phenolic work surface (Photo courtesy of HEMCO Corporation)

Hemco Offers VSE Balance Enclosure for Critical Procedures Involving Powders and Liquids

HEMCO Corporation (Independence, MO, USA) is offering its Vented Safety Enclosure (VSE) in 24-, 36- and 48-inch widths to accommodate an analytical balance and other small-scale lab processes.... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.